In ischemia-reperfusion injury, Kapitsinou et al. showed that activating HIF by pharmacological PHD inhibitor GSK1002083A before ischemia ameliorated AKI-induced fibrosis, but post-ischemic PHD inhibition had no effect on renal fibrosis [100]. This evidence concerns the gene PDC and acute kidney injury.